|
TP53INP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.72790000483059E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.96949950476744E-10 |
| Normal-vs-Stage2 |
1.364460E-02 |
| Normal-vs-Stage3 |
2.411300E-04 |
| Normal-vs-Stage4 |
7.521500E-03 |
| Stage1-vs-Stage2 |
1.769740E-02 |
| Stage1-vs-Stage3 |
2.130000E-02 |
| Stage1-vs-Stage4 |
3.240400E-02 |
| Stage2-vs-Stage3 |
5.107800E-01 |
| Stage2-vs-Stage4 |
8.179200E-01 |
| Stage3-vs-Stage4 |
6.927600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.86559999565605E-08 |
| Normal-vs-AfricanAmerican |
6.418900E-03 |
| Normal-vs-Asian |
1.58279999999955E-05 |
| Caucasian-vs-AfricanAmerican |
9.528600E-01 |
| Caucasian-vs-Asian |
2.732600E-01 |
| AfricanAmerican-vs-Asian |
4.800200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.74219999982128E-07 |
| Normal-vs-Female |
1.94169999967464E-07 |
| Male-vs-Female |
3.998200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.67559999209033E-09 |
| Normal-vs-Age(41-60Yrs) |
2.4310999999777E-06 |
| Normal-vs-Age(61-80Yrs) |
6.655900E-03 |
| Normal-vs-Age(81-100Yrs) |
3.399800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.375600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.478070E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.658600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.224210E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.220800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.122600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.218800E-04 |
| Classical-VS-Follicular |
4.791700E-04 |
| Classical-VS-Other |
9.599000E-01 |
| Classical-VS-Normal |
3.25379945209647E-10 |
| Tall-VS-Follicular |
5.862400E-01 |
| Tall-VS-Other |
7.934200E-02 |
| Tall-VS-Normal |
7.322000E-02 |
| Follicular-VS-Other |
3.046200E-01 |
| Follicular-VS-Normal |
1.449720E-02 |
| Other-VS-Normal |
7.978000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.7094999999775E-06 |
| Normal-vs-N1 |
2.009300E-04 |
| N0-vs-N1 |
3.328600E-01 |
|
|
